DexCom (DXCM) Tops Q3 EPS by 16c; offers guidance
Tweet
Share
E-mailGet Alerts DXCM Hot Sheet
Price: $69.07 --0%
Revenue Growth %: +11.2%
Financial Fact:
Total operating expenses: 119.6M
Today's EPS Names:
JFIN, KEQU, LASE, More
Revenue Growth %: +11.2%
Financial Fact:
Total operating expenses: 119.6M
Today's EPS Names:
JFIN, KEQU, LASE, More
Join SI Premium – FREE
DexCom (NASDAQ: DXCM) reported Q3 EPS of $0.50, $0.16 better than the analyst estimate of $0.34. Revenue for the quarter came in at $975 million versus the consensus estimate of $939.19 million.
GUIDANCE:
DexCom sees FY2023 revenue of $3.575-3.6 million, versus the consensus of $3.539 million.
For earnings history and earnings-related data on DexCom (DXCM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Primoris cuts 2026 outlook on renewables cost overruns, COO exits
- RBC Capital Starts Molina Healthcare (MOH) at Sector Perform
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
